Shark Tank India's Namita Thapar is to receive a whopping of around Rs 127 cr from her recent investor's round. Her brand Emcure Pharmaceuticals' IPO, starting tomorrow, Wednesday, July 3, is expected to raise around Rs 127.87 crore for Namita Thapar, she is a Shark Tank India investor and member of the Emcure Pharmaceuticals promoter group.
Talking about her investments in Shark Tank India, she has had one of the highest solo deals in the three seasons. Namita had recently made an exit from her investment deal from the first season of the show the handicrafts brand. The brand made a huge impact resulting in over 8,000 artisans experiencing a substantial 180% increase in their income, facilitating the education of over 1,000 children.
Talking about her exit, Namita shared, "Rano stands out as a founder who personifies humility, determination, and an unwavering passion for supporting artisans. Meeting his parents in Kolkata left a lasting impression on me—the pride in their eyes while recounting his entrepreneurial journey truly touched my heart. This is one story to watch out for, “picture abhi baaki hai”."
Namita further added, "This is the first Shark Tank India exit for any shark from the show. Everybody had told me 'aree yeh toh CSR hai, ismein thodi paise banenge', when I used to go to the Airport and show my industrialist friends the company and all of them would tell me whether in Shark Tank we make money or just do it for entertainment. When Rano pitched, they were in 4 stores today they are in 50 stores. This isn't just a scale in sales growth. This is one of those rare companies which are pact-positive."
Start a Conversation
Post comment